To unveil the nonnegligible responsibility for the downregulation of ALDH9A1 in ccRCC, epigenetic modifications were taken into consideration, given their substantial significance in biomedical research [23]. Here, ALDH9A1 is linked to nonpapillary renal cell carcinoma.